Psychiatry and Neurology, Neurology · New York, NY
NPI
1477721140
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1275 York Ave, Department of Neurology, Box 52
New York, NY, 10065
Phone (212) 639-7576
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
310 services
Medicare patients, 2024
147
Average age 71
Drug cost, 2024
$810K
316 prescriptions
Company payments, 2024
$0
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eli L Diamond was code 99214 (office e&m - established), 139 times for 58 patients. In total Eli L Diamond billed 310 services in 13 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-12-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 139 | 58 | $82.92 | $12K |
| 99223 Hospital E&M - Initial | Facility | 35 | 35 | $150.69 | $5,274 |
| 99232 Hospital E&M - Subsequent | Facility | 31 | 16 | $68.63 | $2,127 |
| 99233 Hospital E&M - Subsequent | Facility | 24 | 17 | $103.06 | $2,473 |
| 99213 Office E&M - Established | Office | 22 | 20 | $49.91 | $1,098 |
| 99205 Office E&M - New | Office | 19 | 19 | $157.76 | $2,998 |
| 99222 Hospital E&M - Initial | Facility | 17 | 16 | $114.56 | $1,948 |
By year: 2022 $25K for 252 services; 2023 $29K for 314 services; 2024 $29K for 310 services.
Medicare prescription drug claims, 2024
In 2024, the drug Eli L Diamond prescribed most often to Medicare patients was Cotellic (Cobimetinib Fumarate), with 80 prescriptions and refills. In total Eli L Diamond wrote 316 Medicare prescriptions that cost $810K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Cotellic Cobimetinib Fumarate | 80 | 80 | 12 | $275K |
| Tafinlar Dabrafenib Mesylate | 47 | 48 | Under 11 | $295K |
| Mekinist Trametinib Dimethyl Sulfoxide | 26 | 31 | Under 11 | $144K |
| Amantadine Amantadine Hcl | 15 | 15 | Under 11 | $595 |
| Trexall Methotrexate Sodium | 12 | 12 | Under 11 | $3,964 |
| Valproic Acid Valproic Acid (As Sodium Salt) | 12 | 12 | Under 11 | $556 |
| Zelboraf Vemurafenib | 11 | 18 | Under 11 | $32K |
| Methylphenidate Hcl Generic | 11 | 13 | Under 11 | $463 |
Brand drugs: 176 claims; generic drugs: 140 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Eli L Diamond $0 (- in general payments such as food, travel and fees) from 2 companies.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.